Deciphering anti-MOG IgG antibodies: Clinical and radiological spectrum, and comparison of antibody detection assays

Autor: Tzartos, John S., Karagiorgou, Katerina, Tzanetakos, Dimitrios, Breza, Marianthi, Evangelopoulos, Maria Eleftheria, Pelidou, Sygkliti-Henrietta, Bakirtzis, Christos, Nikolaidis, Ioannis, Koutsis, Georgios, Notas, Konstantinos, Chroni, Elisabeth, Markakis, Ioannis, Grigoriadis, Nikolaos C., Anagnostouli, Maria, Orologas, Anastasios, Parisis, Dimitrios, Karapanayiotides, Theodoros, Papadimitriou, Dimitra, Kostadima, Vasiliki, Elloul, John, Xidakis, Iosif, Maris, Thomas, Zisimopoulou, Paraskevi, Tzartos, Socrates, Kilidireas, Costas

Publikováno v: In Journal of the Neurological Sciences 15 March 2020 410

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.

Autor: Brian Lawlor, Ricardo Segurado, Sean Kennelly, Marcel G M Olde Rikkert, Robert Howard, Florence Pasquier, Anne Börjesson-Hanson, Magda Tsolaki, Ugo Lucca, D William Molloy, Robert Coen, Matthias W Riepe, János Kálmán, Rose Anne Kenny, Fiona Cregg, Sarah O'Dwyer, Cathal Walsh, Jessica Adams, Rita Banzi, Laetitia Breuilh, Leslie Daly, Suzanne Hendrix, Paul Aisen, Siobhan Gaynor, Ali Sheikhi, Diana G Taekema, Frans R Verhey, Raffaello Nemni, Flavio Nobili, Massimo Franceschi, Giovanni Frisoni, Orazio Zanetti, Anastasia Konsta, Orologas Anastasios, Styliani Nenopoulou, Fani Tsolaki-Tagaraki, Magdolna Pakaski, Olivier Dereeper, Vincent de la Sayette, Olivier Sénéchal, Isabelle Lavenu, Agnès Devendeville, Gauthier Calais, Fiona Crawford, Michael Mullan, NILVAD Study Group

Publikováno v: PLoS Medicine, Vol 15, Iss 9, p e1002660 (2018)

BACKGROUND:This study reports the findings of the first large-scale Phase III investigator-driven clinical trial to slow the rate of cognitive decline in Alzheimer disease with a dihydropyridine (DHP) calcium channel blocker, nilvadipine. Nilvadipine

Externí odkaz: https://doaj.org/article/96fe8e60d2d245c38445e16c3151fb36

Sedative Load in Community-Dwelling Older Adults with Mild–Moderate Alzheimer’s Disease: Longitudinal Relationships with Adverse Events, Delirium and Falls

Autor: Dyer, Adam H, Murphy, Claire, Lawlor, Brian, Kennelly, Sean, P NILVAD StudyGroup: Brian Lawlor, Ricardo, Segurado, Sean, Kennelly, Marcel G, M Olde Rikkert, Robert, Howard, Florence, Pasquier, Anne, Börjesson-Hanson, Magda, Tsolaki, Ugo, Lucca, D William Molloy, Robert, Coen, Matthias, W Riepe, János, Kálmán, Rose Anne Kenny, Fiona, Cregg, Sarah, O'Dwyer, Cathal, Walsh, Jessica, Adams, Rita, Banzi, Laetitia, Breuilh, Leslie, Daly, Suzanne, Hendrix, Paul, Aisen, Siobhan, Gaynor, Ali, Sheikhi, Diana, G Taekema, Frans, R Verhey, Raffaello, Nemni, Nobili, FLAVIO MARIANO, Massimo, Franceschi, Frisoni, Giovanni, Zanetti, Orazio, Anastasia, Konsta, Orologas, Anastasios, Styliani, Nenopoulou, Fani, Tsolaki-Tagaraki, Magdolna, Pakaski, Olivier, Dereeper, Olivier, Sénéchal, Agnès, Devendeville, Gauthier, Calais, Fiona, Crawford, Michael, Mullan, Pauline, Aalten, Maria, A Berglund, Jurgen, A Claassen, Rianne, A De Heus, Daan L, K De Jong, Olivier, Godefroy, Siobhan, Hutchinson, Aikaterini, Ioannou, Michael, Jonsson, Annette, Kent, Jürgen, Kern, Petros, Nemtsas, Minoa-Kalliopi, Panidou, Laila, Abdullah, Angelina, M Santoso, Gerrita, J van Spijker, Martha, Spiliotou, Georgia, Thomoglou, Anders, Wallin

Publikováno v: Drugs & Aging, 37, 829-837
Drugs & Aging, 37, 11, pp. 829-837

Older adults are frequently prescribed medications with sedative effects, which are associated with numerous adverse consequences. However, the prevalence and longitudinal associations of sedative medication use in community-dwelling older adults wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1744bd9a8b6eebce687ef9898e386df
https://doi.org/10.1007/s40266-020-00800-y

Cognitive Outcomes of Long-term Benzodiazepine and Related Drug (BDZR) Use in People Living With Mild to Moderate Alzheimer's Disease: Results From NILVAD

Autor: Adam H. Dyer, Claire Murphy, Brian Lawlor, Sean P. Kennelly, Ricardo Segurado, Sean Kennelly, Marcel G.M. Olde Rikkert, Robert Howard, Florence Pasquier, Anne Börjesson-Hanson, Magda Tsolaki, Ugo Lucca, D. William Molloy, Robert Coen, Matthias W. Riepe, János Kálmán, Rose Anne Kenny, Fiona Cregg, Sarah O'Dwyer, Cathal Walsh, Jessica Adams, Rita Banzi, Laetitia Breuilh, Leslie Daly, Suzanne Hendrix, Paul Aisen, Siobhan Gaynor, Ali Sheikhi, Diana G. Taekema, Frans R. Verhey, Raffaello Nemni, Flavio Nobili, Massimo Franceschi, Giovanni Frisoni, Orazio Zanetti, Anastasia Konsta, Orologas Anastasios, Styliani Nenopoulou, Fani Tsolaki-Tagaraki, Magdolna Pakaski, Olivier Dereeper, Vincent de la Sayette, Olivier Sénéchal, Isabelle Lavenu, Agnès Devendeville, Gauthier Calais, Fiona Crawford, Michael Mullan, Pauline Aalten, Maria A. Berglund, Jurgen A. Claassen, Rianne A. De Heus, Daan L.K. De Jong, Olivier Godefroy, Siobhan Hutchinson, Aikaterini Ioannou, Michael Jonsson, Annette Kent, Jürgen Kern, Petros Nemtsas, Minoa-Kalliopi Panidou, Laila Abdullah, Daniel Paris, Angelina M. Santoso, Gerrita J. van Spijker, Martha Spiliotou, Georgia Thomoglou, Anders Wallin

Publikováno v: Journal of the American Medical Directors Association, 21, 2, pp. 194-200
Journal of the American Medical Directors Association
Journal of the American Medical Directors Association, 2020, 21 (2), pp.194-200. ⟨10.1016/j.jamda.2019.08.006⟩
Journal of the American Medical Directors Association, 21, 194-200
Journal of the American Medical Directors Association, 21(2), 194-200. Elsevier Science

Contains fulltext : 218263.pdf (Publisher’s version ) (Closed access) OBJECTIVE: Benzodiazepines and related drugs (BDZRs) have been associated with an increased risk of Alzheimer's disease (AD) in later life. Despite this, it remains unclear wheth

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2ece45ec58f613a5a085208e0745f53
https://hdl.handle.net/2066/218263